Transcutaneous vagus nerve stimulation may attenuate postoperative cognitive dysfunction in elderly patients

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 938-941

  Xiong, J ^a   Xue, F S ^a   Liu, J H ^a   Xu, Y C ^a   Liao, X ^a   Zhang, Y M ^a   Wang, W L ^a   Li, S ^a  

^a PLASTIC SURGERY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ELDERLY CARE; HEART SURGERY; HUMAN; INFLAMMATION; JOB PERFORMANCE; LENGTH OF STAY; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION CARE; SIGNAL TRANSDUCTION; THERAPY EFFECT; TRANSCUTANEOUS NERVE STIMULATION; VAGUS NERVE STIMULATION;

AGED; COGNITION DISORDERS; HUMANS; POSTOPERATIVE COMPLICATIONS; VAGUS NERVE;

ANIMALIA;

EID: 70449732565     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.06.033     Document Type: Article

References (38)

1. Laalou F.Z., Carre A.C., Forestier C., Sellal F., Langeron O., and Pain L. Pathophysiology of post-operative cognitive dysfunction: current hypotheses. J Chir (Paris) 145 (2008) 323-330
2. Gao L., Taha R., Gauvin D., Othmen L.B., Wang Y., and Blaise G. Postoperative cognitive dysfunction after cardiac surgery. Chest 128 (2005) 3664-3670
3. Wan Y., Xu J., Ma D., Zeng Y., Cibelli M., and Maze M. Postoperative impairment of cognitive function in Rats. Anesthesiology 106 (2007) 436-443
4. Xie G.L., Zhang W., Chang Y.Z., and Chu Q.J. Relationship between perioperative inflammatory response and postoperative cognitive dysfunction in the elderly. Med Hypotheses 73 (2009) 402-403
5. Ramlawi B., Rudolph J.L., Mieno S., Feng J., Boodhwani M., Khabbaz K., et al. C-reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery 140 (2006) 221-226
6. Johnston G.R., and Webster N.R. Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth 102 (2009) 453-462
7. Groves D.A., and Brown V.J. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 29 (2005) 493-500
8. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiat 65 (2009) 304-312
9. Brenner T., Nizri E., Irony-Tur-Sinai M., Hamra-Amitay Y., and Wirguin I. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia gravis and neuroinflammation. J Neuroimmunol 201-202 (2008) 121-127
10. Bermejo P., Martín-Aragón S., Benedí J., Susín C., Felici E., Gil P., et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 117 (2008) 198-202
11. Tobinick E.L., and Gross H. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammat 5 (2008) 2
12. Rosczyk H.A., Sparkman N.L., and Johnson R.W. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp Gerontol 43 (2008) 840-846
13. Ni Choileain N., and Redmond H.P. Cell response to surgery. Arch Surg 141 (2006) 1132-1140
14. Guyon A., Massa F., Rovère C., and Nahon J.L. How cytokines can influence the brain: a role for chemokines?. J Neuroimmunol 198 (2008) 46-55
15. Kálmán J., Juhász A., Bogáts G., Babik B., Rimanóczy A., Janka Z., et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 48 (2006) 177-180
16. Wilson C.J., Finch C.E., and Cohen H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50 (2002) 2041-2056
17. Liu C.L., Zhao W.X., and Huang W.Q. Advance in research of cholinergic anti-inflammatory pathway (Chinese). Int J Anesth Resus 28 (2007) 59-62
18. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
19. Pavlov V.A. Cholinergic modulation of inflammation. Int J Clin Exp Med 1 (2008) 203-212
20. Xiong J., Xue F.S., Xu Y.C., Yang Q.Y., Liao X., and Wang W.L. Cholinergic agonists may produce preservation of myocardial ischemia/reperfusion injury. Med Hypotheses 73 (2009) 312-314
21. van Westerloo D.J., Giebelen I.A., Florquin S., Bruno M.J., Larosa G.J., Ulloa L., et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130 (2006) 1822-1830
22. Huston J.M., Gallowitsch-Puerta M., Ochani M., Ochani K., Yuan R., Rosas-Ballina M., et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 35 (2007) 2762-2768
23. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201 (2005) 1113-1123
24. Wittebole X., Hahm S., Coyle S.M., Kumar A., Calvano S.E., and Lowry S.F. Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 147 (2007) 28-34
25. Giebelen I.A., van Westerloo D.J., LaRosa G.J., de Vos A.F., and van der Poll T. Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism. Shock 27 (2007) 443-447
26. Nizri E., Hamra-Amitay Y., Sicsic C., Lavon I., and Brenner T. Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 50 (2006) 540-547
27. Reale M., Iarlori C., Gambi F., Feliciani C., Isabella L., and Gambi D. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology 50 (2006) 606-613
28. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
29. George M.S., Nahas Z., Borckardt J.J., Anderson B., Burns C., Kose S., et al. Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Expert Rev Neurother 7 (2007) 63-74
30. Fallgatter A.J., Ehlis A.C., Ringel T.M., and Herrmann M.J. Age effect on far field potentials from the brainstem after transcutaneous vagus nerve stimulation. Int J Psychophysiol 56 (2005) 37-43
31. Seymour D.G., and Severn A.M. Cognitive dysfunction after surgery and anaesthesia: what can we tell the grandparents?. Age Ageing 38 (2009) 147-150
32. Townsend K.P., and Praticò D. Novel therapeutic opportunities for Alzheimer's disease focus on nonsteroidal anti-inflammatory drugs. FASEB J 19 (2005) 1592-1601
33. Jaseja H. Vagal nerve stimulation: exploring its efficacy and success for an improved prognosis and quality of life in cerebral palsy patients. Clin Neurol Neurosurg 110 (2008) 755-762
34. Sackeim H.A., Keilp J.G., Rush A.J., George M.S., Marangell L.B., Dormer J.S., et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiat Neuropsychol Behav Neurol 14 (2001) 53-62
35. Das U.N. Vagus nerve stimulation, depression and inflammation. Neuropsychopharmacology 32 (2007) 2053-2054
36. Helmstaedter C., Hoppe C., and Elger C.E. Memory alterations during acute high intensity vagus nerve stimulation. Epilepsy Res 47 (2001) 37-42
37. Praticò C., Quattrone D., Lucanto T., Amato A., Penna O., Roscitano C., et al. Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium. Med Hypotheses 65 (2005) 972-982
38. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5 (2005) 331-342